C.M. Bidwell & Associates’s Cross Country Healthcare CCRN Stock Holding History

C.M. Bidwell & Associates’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,335	Closed	-$52.1K	–	524
2023 Q1	$52.1K	Hold	2,335	–	–	0.04%	293
2022 Q4	$62K	Sell	2,335 -195	-8%	-$6.37K	0.05%	278
2022 Q3	$72K	Sell	2,530 -9,875	-80%	-$254K	0.06%	257
2022 Q2	$258K	Sell	12,405 -3,830	-24%	-$71.8K	0.2%	82
2022 Q1	$352K	Hold	16,235	–	–	0.23%	71
2021 Q4	$451K	Sell	16,235 -1,580	-9%	-$38.3K	0.28%	59
2021 Q3	$378K	Sell	17,815 -7,640	-30%	-$143K	0.25%	63
2021 Q2	$420K	Sell	25,455 -3,530	-12%	-$53.9K	0.28%	59
2021 Q1	$362K	Sell	28,985 -4,915	-14%	-$52.1K	0.26%	54
2020 Q4	$301K	Buy	+33,900	New	+$276K	0.25%	60

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

C.M. Bidwell & Associates's CCRN Position: Q2 2023 in Review

C.M. Bidwell & Associates sold out of Cross Country Healthcare (CCRN) in Q2 2023, closing a stake of 2,335 shares — an estimated $52.1K sold.

C.M. Bidwell & Associates first reported a position in CCRN in Q4 2020 and held it in 10 quarters. The position peaked at $451K in Q4 2021. 194 funds tracked by Wall St. Rank hold CCRN as of Q2 2023.

C.M. Bidwell & Associates reported no remaining Cross Country Healthcare position as of Q2 2023 after selling out during the quarter.
C.M. Bidwell & Associates sold 2,335 Cross Country Healthcare shares in Q2 2023, an estimated $52.1K.
C.M. Bidwell & Associates first reported a position in Cross Country Healthcare in Q4 2020 and held it in 10 quarters.
C.M. Bidwell & Associates's Cross Country Healthcare position peaked at $451K in Q4 2021.
194 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2023, filed 14 Aug 2023.